USPTO Trademark Application for TRI-VYLIBRA AX
Summary
The USPTO has received an intent-to-use trademark application for the mark TRI-VYLIBRA AX, filed on November 12, 2025. The application is for oral contraceptives.
What changed
The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application for the mark TRI-VYLIBRA AX. The application, filed on November 12, 2025, under application number 99492415, is specifically for use in connection with oral contraceptives.
This filing signifies the applicant's intent to use the mark in commerce for pharmaceutical products. While this is an intent-to-use application and not a final registration, it indicates a planned product launch in the oral contraceptive market. Companies operating in this space should be aware of new brand entries and potential trademark conflicts.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
TRI-VYLIBRA AX
Intent to Use TM99492415 Kind: intenttouse Mar 22, 2026
Abstract
Oral contraceptives
Filing Date
2025-11-12
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.